JENNIFER SWEARINGEN: Open Payments
NPI 1497773634 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,107 in 148 payments from 18 companies in 2025. Trend: 2023 $1,885 · 2024 $3,092 · 2025 $3,107
Food & beverage: $3,013Education: $94
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $732 |
| Janssen Biotech, Inc. | 18 | $554 |
| Aimmune Therapeutics, Inc. | 15 | $363 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $326 |
| PFIZER INC. | 16 | $244 |
| Lilly USA, LLC | 10 | $181 |
| QOL Medical, LLC | 7 | $120 |
| Madrigal Pharmaceuticals | 5 | $102 |
| GENZYME CORPORATION | 4 | $96 |
| Ardelyx, Inc. | 5 | $91 |
Products named: TREMFYA, ZENPEP, RINVOQ, ENTYVIO, SKYRIZI, OMVOH, VELSIPITY, DUPIXENT.
Industry payments across NC — which companies pay providers there.
